4883.T
Price:
$30
Market Cap:
$2.89B
Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2020-08-03
Stock Exchange
JPX
Ticker
4883.T
According to Modalis Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -1.25. This represents a change of -53.48% compared to the average of -2.69 of the last 4 quarters.
The mean historical PE Ratio of Modalis Therapeutics Corporation over the last ten years is 31.92. The current -1.25 PE Ratio has changed -491.62% with respect to the historical average. Over the past ten years (40 quarters), 4883.T's PE Ratio was at its highest in in the March 2020 quarter at 0. The PE Ratio was at its lowest in in the December 2024 quarter at -6.69.
Average
31.92
Median
-2.79
Minimum
-129.96
Maximum
419.96
Discovering the peaks and valleys of Modalis Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 419.96
Minimum Annual Increase = -130.95%
Minimum Annual PE Ratio = -129.96
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.01 | -43.70% |
| 2024 | -3.57 | 122.39% |
| 2023 | -1.61 | -55.50% |
| 2022 | -3.61 | -84.87% |
| 2021 | -23.85 | -81.65% |
| 2020 | -129.96 | -130.95% |
| 2019 | 419.96 | Infinity% |
The current PE Ratio of Modalis Therapeutics Corporation (4883.T) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.40
5-year avg
-6.93
10-year avg
31.92
Modalis Therapeutics Corporation’s PE Ratio is less than SymBio Pharmaceuticals Limited (-0.53), greater than Nippon Chemiphar Co., Ltd. (-44.90), greater than Cyfuse Biomedical K.K. (-7.43), less than WDB coco Co., Ltd. (0.95), greater than PRISM BioLab Co.,LTD (-5.82), greater than MedRx Co., Ltd (-3.94), greater than Solasia Pharma K.K. (-8.11), less than Shigematsu Works Co., Ltd. (8.11), less than Pharmarise Holdings Corporation (59.36), greater than D. Western Therapeutics Institute, Inc. (-5.88),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.53 | $2.92B | |
| -44.90 | $5.59B | |
| -7.43 | $6.11B | |
| 0.95 | $6.21B | |
| -5.82 | $5.10B | |
| -3.94 | $3.32B | |
| -8.11 | $7.37B | |
| 8.11 | $6.39B | |
| 59.36 | $5.80B | |
| -5.88 | $4.02B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modalis Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Modalis Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Modalis Therapeutics Corporation's PE Ratio?
How is the PE Ratio calculated for Modalis Therapeutics Corporation (4883.T)?
What is the highest PE Ratio for Modalis Therapeutics Corporation (4883.T)?
What is the 3-year average PE Ratio for Modalis Therapeutics Corporation (4883.T)?
What is the 5-year average PE Ratio for Modalis Therapeutics Corporation (4883.T)?
How does the current PE Ratio for Modalis Therapeutics Corporation (4883.T) compare to its historical average?